ZNF281 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.917850E-01
Normal-vs-Stage2
3.937000E-01
Normal-vs-Stage3
1.340400E-01
Normal-vs-Stage4
9.732400E-01
Stage1-vs-Stage2
7.687600E-01
Stage1-vs-Stage3
3.449200E-01
Stage1-vs-Stage4
2.733200E-01
Stage2-vs-Stage3
3.174800E-01
Stage2-vs-Stage4
3.030800E-01
Stage3-vs-Stage4
1.932020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.182200E-01
Normal-vs-AfricanAmerican
4.607400E-01
Normal-vs-Asian
1.947440E-01
Caucasian-vs-AfricanAmerican
8.064200E-01
Caucasian-vs-Asian
5.911400E-01
AfricanAmerican-vs-Asian
5.496000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.786600E-01
Normal-vs-Female
2.891200E-01
Male-vs-Female
8.713800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.074400E-01
Normal-vs-Age(41-60Yrs)
4.987800E-01
Normal-vs-Age(61-80Yrs)
3.238000E-01
Normal-vs-Age(81-100Yrs)
1.196200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.577000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.761600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.959200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.162400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.343700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.315600E-02
Normal-vs-Daily Drinker
8.038300E-02
Normal-vs-Weekly Drinker
4.570800E-01
Normal-vs-Occasional Drinker
5.203000E-01
Normal-vs-Social Drinker
9.333400E-01
Non Drinker-vs-Daily Drinker
6.320000E-01
Non Drinker-vs-Weekly Drinker
1.299220E-01
Non Drinker-vs-Occasional Drinker
1.443970E-01
Non Drinker-vs-Social Drinker
1.218440E-01
Daily Drinker-vs-Weekly Drinker
9.006200E-02
Daily Drinker-vs-Occasional Drinker
9.728200E-02
Daily Drinker-vs-Social Drinker
9.346300E-02
Weekly Drinker-vs-Occasional Drinker
9.999600E-01
Weekly Drinker-vs-Social Drinker
5.113200E-01
Occasional Drinker-vs-Social Drinker
4.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.816000E-01
Normal-vs-Grade 2
6.300400E-02
Normal-vs-Grade 3
1.603360E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.918400E-01
Grade 1-vs-Grade 3
8.924000E-02
Grade 1-vs-Grade 4
2.816000E-01
Grade 2-vs-Grade 3
2.099200E-01
Grade 2-vs-Grade 4
6.300400E-02
Grade 3-vs-Grade 4
1.603360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.637600E-01
Normal-vs-NonDiabetic
1.613220E-01
Diabetic-vs-NonDiabetic
6.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.950000E-02
Normal-vs-NoPancreatitis
3.000000E-01
Pancreatitis-vs-NoPancreatitis
7.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.152400E-01
Normal-vs-N1
3.069200E-01
N0-vs-N1
6.730000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.410200E-01
Normal-vs-TP53-NonMutant
1.630210E-01
TP53-Mutant-vs-TP53-NonMutant
1.963410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
